Menu
Back to Journals » Cancer Management and Research » Volume 13
RETRACTED ARTICLE: LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p
Authors Yu H, Dong L, Wang H, Zhang Y, Wang Z, Wang C, Xia H, Bao H
Received 9 August 2020
Accepted for publication 26 January 2021
Published 22 February 2021 Volume 2021:13 Pages 1803—1815
DOI https://doi.org/10.2147/CMAR.S276290
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Bilikere Dwarakanath
This paper has been retracted.
Yu H, Dong L, Wang H, et al. Cancer Manag Res. 2021;13:1803–1815.
We, the Editor and Publisher of Cancer Management and Research are retracting the published article. Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.